Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Frontiers in Immunology
|
February 14, 2022
CD19 CAR-T Cell Therapy Induced Immunotherapy Associated Interstitial Pneumonitis: A Case Report
Zhuanyi Sun, Caiqin Xie, Hui Liu, et al.
Frontiers in Immunology
|
June 27, 2022
Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy
Weiguo Zhu, Shi Tao, Wenchun Miao, et al.
Scientific Reports
|
December 13, 2022
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
Xianggui Yuan, Teng Yu, Yurong Huang, et al.
Frontiers in Oncology
|
July 21, 2025
Case Report: Primary cardiac diffuse large B-cell lymphoma with sick sinus syndrome and literature review on disease management and therapeutic strategies
Xiaofen Qiu, Li Zhang, Shaojun Zhou, et al.
Blood Cells, Molecules & Diseases
|
January 30, 2010
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias
Yungui Wang, Zejuan Li, Chunjiang He, et al.
Frontiers in Immunology
|
April 23, 2026
Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study
Yan Lu, Shiguang Ye, Lili Zhou, et al.
Journal of Zhejiang University. Science. B
|
August 8, 2023
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review
Xueli Jin, Hui Liu, Jing Li, et al.
Frontiers of Medicine
|
July 7, 2023
Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients
Xianggui Yuan, Teng Yu, Jianzhi Zhao, et al.
Omics : a Journal of Integrative Biology
|
May 17, 2023
miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of <i>ERBB4</i>
Huawei Jiang, Zhiwei Su, Wangxiong Hu, et al.
Frontiers in Immunology
|
December 12, 2022
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
Xianggui Yuan, Xian Li, Yurong Huang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Frontiers in Immunology
|
February 14, 2022
CD19 CAR-T Cell Therapy Induced Immunotherapy Associated Interstitial Pneumonitis: A Case Report
Zhuanyi Sun, Caiqin Xie, Hui Liu, et al.
Frontiers in Immunology
|
June 27, 2022
Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy
Weiguo Zhu, Shi Tao, Wenchun Miao, et al.
Scientific Reports
|
December 13, 2022
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
Xianggui Yuan, Teng Yu, Yurong Huang, et al.
Frontiers in Oncology
|
July 21, 2025
Case Report: Primary cardiac diffuse large B-cell lymphoma with sick sinus syndrome and literature review on disease management and therapeutic strategies
Xiaofen Qiu, Li Zhang, Shaojun Zhou, et al.
Blood Cells, Molecules & Diseases
|
January 30, 2010
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias
Yungui Wang, Zejuan Li, Chunjiang He, et al.
Frontiers in Immunology
|
April 23, 2026
Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study
Yan Lu, Shiguang Ye, Lili Zhou, et al.
Journal of Zhejiang University. Science. B
|
August 8, 2023
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review
Xueli Jin, Hui Liu, Jing Li, et al.
Frontiers of Medicine
|
July 7, 2023
Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients
Xianggui Yuan, Teng Yu, Jianzhi Zhao, et al.
Omics : a Journal of Integrative Biology
|
May 17, 2023
miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of <i>ERBB4</i>
Huawei Jiang, Zhiwei Su, Wangxiong Hu, et al.
Frontiers in Immunology
|
December 12, 2022
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
Xianggui Yuan, Xian Li, Yurong Huang, et al.
Page
of 2